Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 11, Issue 11, Pages 1758-1765Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2011.07.002
Keywords
Lactic acid bacteria; Lactobacillus johnsonii HY7042; Vaginosis; Gardnerella vaginalis; Antimicrobial effect
Categories
Ask authors/readers for more resources
Hydrogen peroxide-producing lactic acid bacteria (LAB) were isolated from women's vaginas and their anti-inflammatory effects against Gardnerella vaginalis-induced vaginosis were examined in beta-estradiol-immunosuppressed mice. Oral and intravaginal treatment with five LABs significantly decreased viable G. vaginalis numbers in vaginal cavities and myeloperoxidase activity in mouse vaginal tissues. Of the LABs examined, Lactobacillus johnsonii HY7042 (LJ) most potently inhibited G. vaginalis-induced vaginosis. This LAB also inhibited the expressions of IL-1 beta, IL-6, TNF-alpha, COX-2, and iNOS, and the activation of NF-kappa B in vaginal tissues, but increased IL-10 expression. Orally administered LJ (0.2 x 10(8) CFU/mouse) also inhibited the expression of TNF-alpha by 91.7% in beta-estradiol-immunosuppressed mice intraperitoneally injected with LPS. However, it increased IL-10 expression by 63.3% in these mice. Furthermore, LJ inhibited the expressions of the pro-inflammatory cytokines, TNF-alpha and IL-1 beta, and the activation of NF-kappa B in lipopolysaccharide-stimulated peritoneal macrophages. LJ also killed G. vaginalis attached with and without HeLa cells. These findings suggest that LJ inhibits bacterial vaginosis by inhibiting the expressions of COX-2, iNOS, IL-1 beta, and TNF-alpha by regulating NF-kappa B activation and by killing G. vaginalis, and that LJ could ameliorate bacterial vaginosis. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available